Search Within

Monica Morrow

  1. "Sujata Patil"
Formats
  1. Journal Article (45)
  2. Meeting Abstract (38)
Groups
  1. Biostatistics Service (83)
  2. Epidemiology and Biostatistics (83)
  3. Surgery (83)
  4. Survivorship Research (51)
  5. Department of Medicine (28)
  6. Solid Tumor Oncology Division (28)

More Groups

People
  1. Sujata Patil (83)
  2. Michelle Stempel (36)
  3. Kimberly Van Zee (26)
  4. Edi Brogi (21)
  5. Larry Norton (18)
  6. Mary Gemignani (18)

More People

Years
  1. 2020 (1)
  2. 2019 (3)
  3. 2018 (3)
  4. 2017 (11)
  5. 2016 (8)
  6. 2015 (10)

More Years

Publications
  1. Annals of Surgical Oncology (39)
  2. Journal of Clinical Oncology (16)
  3. Cancer Research (8)
  4. Cancer (4)
  5. Annals of Surgery (3)
  6. Breast Cancer Research and Treatment (3)

More Publications

Publishers
  1. Springer (42)
  2. American Society of Clinical Oncology (16)
  3. American Association for Cancer Research (12)
  4. Wiley Blackwell (4)
  5. Lippincott Williams & Wilkins (3)
  6. Elsevier Inc. (2)

More Publishers

Results (83)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Microscopic extracapsular extension in sentinel lymph nodes does not mandate axillary dissection in Z0011-eligible patients
    Journal Article

    Barrio, A. V.; Downs-Canner, S.; Edelweiss, M.; Van Zee, K. J.; Cody, H. S. 3rd; Gemignani, M. L.; Pilewskie, M. L.; Plitas, G.; El-Tamer, M.; Kirstein, L.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC)
    Meeting Abstract

    Comen, E. A.; Bryce, Y.; Page, D. B.; Solomon, S. B.; Rodine, M.; Abaya, C. D.; Morris, E. A.; Plitas, G.; El-Tamer, M.; Gemignani, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Microscopic extracapsular extension in sentinel lymph nodes does not mandate axillary dissection in Z0011-eligible patients
    Meeting Abstract

    Barrio, A. V.; Downs-Canner, S.; Cody, H. S.; Van Zee, K. J.; Gemignani, M. L.; Pilewskie, M.; Plitas, G.; El-Tamer, M.; Kirstein, L.; Capko, D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Journal Article

    Krystel-Whittemore, M.; Xu, J.; Brogi, E.; Ventura, K.; Patil, S.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Most breast cancer patients with T1-2 tumors and one to three positive lymph nodes do not need postmastectomy radiotherapy
    Journal Article

    Muhsen, S.; Moo, T. A.; Patil, S.; Stempel, M.; Powell, S.; Morrow, M.; El-Tamer, M.
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Chemotherapy with and without trastuzumab or no treatment in elderly patients with HER2 amplified breast cancer at a single center
    Meeting Abstract

    Muhsen, S.; Dang, C.; Plitas, G.; Seier, K.; Stempel, M.; Patil, S.; Morrow, M.; El-Tamer, M.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Frequency of delivery of systemic chemotherapy in elderly versus younger patients with triple negative breast cancer
    Meeting Abstract

    Muhsen, S.; Dang, C.; Plitas, G.; Knezevic, A.; Stempel, M.; Patil, S.; Morrow, M.; El-Tamer, M.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Outcomes for women with minimal-volume ductal carcinoma in situ completely excised at core biopsy
    Journal Article

    Muhsen, S.; Barrio, A. V.; Miller, M.; Olcese, C.; Patil, S.; Morrow, M.; Van Zee, K. J.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Contralateral breast cancer risk in women with ductal carcinoma in situ: Is it high enough to justify bilateral mastectomy?
    Journal Article

    Miller, M. E.; Muhsen, S.; Olcese, C.; Patil, S.; Morrow, M.; Van Zee, K. J.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Standard pathologic features can be used to identify a subset of estrogen receptor-positive, HER2 negative patients likely to benefit from neoadjuvant chemotherapy
    Journal Article

    Petruolo, O. A.; Pilewskie, M.; Patil, S.; Barrio, A. V.; Stempel, M.; Wen, H. Y.; Morrow, M.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save